2'3'-cGAMP (sodium salt): Next-Generation Insights in STI...

2025-09-28

Explore the cutting-edge role of 2'3'-cGAMP (sodium salt) as a potent STING agonist in cancer immunotherapy and antiviral innate immunity. This article uniquely focuses on strategic design, optimization, and translational challenges, offering a scientific perspective distinct from existing reviews.

2'3'-cGAMP (Sodium Salt): Unraveling Noncanonical STING-J...

2025-09-27

Explore how 2'3'-cGAMP (sodium salt) advances cancer immunotherapy by uniquely dissecting the interplay between STING and JAK1 signaling. This article offers a deep dive into type I interferon induction and novel mechanisms distinct from conventional cGAS-STING pathway studies.

2'3'-cGAMP (sodium salt): Advanced Insights for Engineeri...

2025-09-26

Explore how 2'3'-cGAMP (sodium salt) redefines research on the cGAS-STING signaling pathway and type I interferon induction. This article offers a unique systems immunology perspective on leveraging this STING agonist for next-generation cancer immunotherapy and antiviral innate immunity.

2'3'-cGAMP (sodium salt): Unlocking Endothelial STING Sig...

2025-09-25

Explore the pivotal role of 2'3'-cGAMP (sodium salt) in modulating endothelial STING signaling for advanced immunotherapy research. This in-depth analysis reveals emerging mechanisms and translational opportunities beyond standard innate immune activation.

2025-09-24

Explore how 2'3'-cGAMP (sodium salt) advances our understanding of cancer immunotherapy through its unique activation of endothelial STING-JAK1 signaling. This article offers a scientific deep-dive into cyclic GMP-AMP's role in tumor vasculature normalization and next-generation immunotherapy research.

2'3'-cGAMP (sodium salt): Expanding Horizons in STING-Med...

2025-09-23

Explore the multifaceted roles of 2'3'-cGAMP (sodium salt) in activating the STING pathway, with a focus on recent discoveries in endothelial cell signaling and implications for cancer immunotherapy. This article offers advanced insights into cyclic GMP-AMP–driven type I interferon induction and the evolving landscape of immunotherapy research.

2'3'-cGAMP (sodium salt): Dissecting Cell-Specific STING ...

2025-09-22

This article explores 2'3'-cGAMP (sodium salt) as a precise molecular tool for dissecting cell-type–specific signaling in the cGAS-STING pathway, with a focus on its implications for cancer immunotherapy and antiviral innate immunity. We highlight new research revealing endothelial-specific STING-JAK1 interactions and discuss how these insights can refine experimental approaches.

2'3'-cGAMP (sodium salt): Advancing STING Agonist Applica...

2025-09-19

Explore the mechanistic and translational insights of 2'3'-cGAMP (sodium salt), a potent STING agonist, in modulating tumor vasculature and type I interferon induction. This article provides a rigorous analysis of its utility in cancer immunotherapy research and antiviral innate immunity, integrating recent advances in the cGAS-STING signaling pathway.

2'3'-cGAMP (sodium salt): Unraveling Endothelial-STING Dy...

2025-09-18

Explore how 2'3'-cGAMP (sodium salt), a potent STING agonist, advances our understanding of endothelial STING-mediated innate immune responses and tumor vasculature normalization. This article highlights recent mechanistic insights and practical research applications for cancer immunotherapy.

According to their structures and substrate

2025-03-03

According to their structures and substrate specificity, MMPs are divided into five major groups: collagenases (e.g., MMP1), gelatinases (e.g., MMP2, MMP9), stromelysins (e.g., MMP3, MMP10), matrilysins (e.g., MMP7), and membrane-type MMPs [7]. Among them, MMP1 is a major collagenase that degrades t

To confirm a role of OCT

2025-03-03

To confirm a role of OCT3 in corticosterone-induced potentiation of cocaine-primed reinstatement, we examined the interaction of corticosterone and cocaine in the reinstatement of cocaine conditioned place preference (CPP) in wild type mice, and transgenic OCT3-deficient mice. These mice express a t

ezh2 inhibitor br Introduction Nausea and vomiting are among

2025-03-03

Introduction Nausea and vomiting are among the most distressing side effects associated with chemotherapy in cancer patients (Billio et al., 2010). Severe emesis can negatively affect a patient's nutritional state, ability to work and motivation, which can, in turn, interfere with the clinical co

Curcumin is the principal natural polyphenol curcuminoid of

2025-03-03

Curcumin is the principal natural polyphenol curcuminoid of turmeric (Curcuma longa) rhizome, a member of the ginger family (Zingiberaceae) [13]. Curcumin has a wide spectrum of therapeutic properties, and it has been shown to possess antioxidant, anti-inflammatory, anticancer, antiangiogenesis, che

The purpose of the present study is to characterize

2025-03-03

The purpose of the present study is (1) to characterize AChE from the monogonont B. koreanus and to analyze the modulation of the AChE activity and its transcription level after exposure to six pharmaceuticals, (2) to evaluate the usefulness of AChE as a molecular biomarker upon pharmaceutical expos

The anorexic effect observed when AR is infused into

2025-03-03

The anorexic effect observed when AR231630 is infused into the VTA could be the result of the DA release inhibition, as previously described [11]. However, there is also a hedonic aspect in feeding that possibly involves dopaminergic mechanisms of reward. Helm et al. showed a functional link between